A股異動 | 康德萊(603987.SH)漲停創歷史新高 績後累計漲幅達30%
格隆匯5月14日丨康德萊(603987.SH)強勢拉昇漲停封板,報24.62元創歷史新高,成交額超3億元,總市值近110億元。康德萊4月初公佈業績,一季度淨利升44.47%至4553.64萬元;歸屬於上市公司股東的扣除非經常性損益的淨利潤4461.37萬元增46.26%。此前公司表示,主營業務為醫用穿刺器械,其中與疫苗相關的小規格注射器佔比相對較小。該股年內股價近乎翻倍,首季業績披露後累計漲幅達30%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.